Two high blood pressure, depression drugs to be withdrawn from market

Two drugs used to treat high blood pressure and depression will be withdrawn from the Taiwan market in early 2025 and late 2024, according to the Taiwan Food and Drug Administration (TFDA), which noted that locally produced generic drugs will fill the gap.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)